By Sheri Kasprzak
New York, April 7 - ViRexx Medical Corp. said it has concluded its previously announced private placement for C$960,000.
The company sold 800,000 units at C$1.20 each.
The units consist of one share and one warrant. The warrants are exercisable at C$1.75 each for two years.
The non-brokered deal priced March 3 as a C$2 million offering of up to 1,666,666 units.
Proceeds will be used for product development, working capital and general corporate purposes.
Based in Edmonton, Alta., ViRexx develops treatments for cancers and hepatitis B and C.
| Issuer: | ViRexx Medical Corp.
|
| Issue: | Units of one share and one warrant
|
| Amount: | C$960,000
|
| Units: | 800,000
|
| Price: | C$1.20
|
| Warrants: | One warrant per unit
|
| Warrant expiration: | Two years
|
| Warrant strike price: | C$1.75
|
| Placement agent: | Non-brokered
|
| Pricing date: | March 3
|
| Settlement date: | April 7
|
| Stock symbol: | Toronto: VIR
|
| Stock price: | C$1.38 at close March 3
|
| Stock price: | C$1.35 at close April 7
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
